Literature DB >> 19318313

Suppression of interleukin-17 by type I interferons: a contributing factor in virus-induced immunosuppression?

Herbert Tilg1, Alexander R Moschen, Arthur Kaser.   

Abstract

Type I interferons (IFNs) are the first line of defence after various infections, and, as immunomodulatory cytokines, bridge innate and adaptive immunity. IL-17, mainly secreted by specific T cells, has recently been identified regulating neutrophil-mediated inflammation, and has been implicated in the pathogenesis of many acute and chronic inflammatory disorders. This cytokine is considered of critical importance for an effective anti-bacterial and anti-fungal immune response as needed subsequent to many viral infections. Recent studies have demonstrated that type I IFNs potently suppress IL-17 expression and Th17 differentiation in vitro and in vivo. Therefore, suppression of IL-17, as well as many other well-defined interactions of type I IFNs with the cytokine cascade, may contribute to virus-induced immunosuppression making the host vulnerable to bacterial and fungal attacks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318313     DOI: 10.1684/ecn.2009.0141

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  6 in total

Review 1.  Postinfluenza bacterial pneumonia: host defenses gone awry.

Authors:  Megan N Ballinger; Theodore J Standiford
Journal:  J Interferon Cytokine Res       Date:  2010-09       Impact factor: 2.607

2.  Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice.

Authors:  Benjamin Lee; Keven M Robinson; Kevin J McHugh; Erich V Scheller; Sivanarayana Mandalapu; Chen Chen; Y Peter Di; Michelle E Clay; Richard I Enelow; Patricia J Dubin; John F Alcorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

3.  Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance.

Authors:  Dhiraj Acharya; Penghua Wang; Amber M Paul; Jianfeng Dai; David Gate; Jordan E Lowery; Dobrivoje S Stokic; A Arturo Leis; Richard A Flavell; Terrence Town; Erol Fikrig; Fengwei Bai
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  Sarsasapogenin-AA13 inhibits LPS-induced inflammatory responses in macrophage cells in vitro and relieves dimethylbenzene-induced ear edema in mice.

Authors:  Dong Dong; Nan-Nan Zhou; Rui-Xuan Liu; Jia-Wei Xiong; Hui Pan; Si-Qi Sun; Lei Ma; Rui Wang
Journal:  Acta Pharmacol Sin       Date:  2017-02-27       Impact factor: 6.150

5.  Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.

Authors:  Thomas J Scriba; Adam Penn-Nicholson; Smitha Shankar; Tom Hraha; Ethan G Thompson; David Sterling; Elisa Nemes; Fatoumatta Darboe; Sara Suliman; Lynn M Amon; Hassan Mahomed; Mzwandile Erasmus; Wendy Whatney; John L Johnson; W Henry Boom; Mark Hatherill; Joe Valvo; Mary Ann De Groote; Urs A Ochsner; Alan Aderem; Willem A Hanekom; Daniel E Zak
Journal:  PLoS Pathog       Date:  2017-11-16       Impact factor: 6.823

6.  Decreased Frequencies of Th17 and Tc17 Cells in Patients Infected with Avian Influenza A (H7N9) Virus.

Authors:  Jiaqi Bao; Dawei Cui; Xiaochen Wang; Qianda Zou; Dejian Zhao; Shufa Zheng; Fei Yu; Li Huang; Yuejiao Dong; Xianzhi Yang; Guoliang Xie; Weizhen Chen; Yu Chen
Journal:  J Immunol Res       Date:  2019-04-02       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.